Guijing Wang1, Heesoo Joo2, Xin Tong2, Mary G George2. 1. From the Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, GA (G.W., X.T., M.G.G.); and IHRC Inc (H.J.), Atlanta, GA. Gbw9@cdc.gov. 2. From the Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, GA (G.W., X.T., M.G.G.); and IHRC Inc (H.J.), Atlanta, GA.
Abstract
BACKGROUND AND PURPOSE: Hospital costs associated with atrial fibrillation (AFib) among patients with stroke have not been well-studied, especially among people aged <65 years. We estimated the AFib-associated hospital costs in US patients aged 18 to 64 years. METHODS: We identified hospital admissions with a primary diagnosis of ischemic stroke from the 2010 to 2012 MarketScan Commercial Claims and Encounters inpatient data sets, excluding those with capitated health insurance plans, aged <18 or >64 years, missing geographic region, hospital costs below the 1st or above 99th percentile, and having carotid intervention (n=40 082). We searched the data for AFib and analyzed the costs for nonrepeat and repeat stroke admissions separately. We estimated the AFib-associated costs using multivariate regression models controlling for age, sex, geographic region, and Charlson comorbidity index. RESULTS: Of the 33 500 nonrepeat stroke admissions, 2407 (7.2%) had AFib. Admissions with AFib cost $4991 more than those without AFib ($23 770 versus $18 779). For the 6582 repeat stroke admissions, 397 (6.0%) had AFib. The costs were $3260 more for those with AFib than those without ($24 119 versus $20 929). After controlling for potential confounders, AFib-associated costs for nonrepeat stroke admissions were $4905, representing 20.6% of the total costs for the admissions. Both the hospital costs and the AFib-associated costs were associated with age, but not with sex. AFib-associated costs for repeat stroke admissions were not significantly higher than for non-AFib patients, except for those aged 55 to 64 years ($3537). CONCLUSIONS: AFib increased the hospital cost of ischemic stroke substantially. Further investigation on AFib-associated costs for repeat stroke admissions is needed.
BACKGROUND AND PURPOSE: Hospital costs associated with atrial fibrillation (AFib) among patients with stroke have not been well-studied, especially among people aged <65 years. We estimated the AFib-associated hospital costs in US patients aged 18 to 64 years. METHODS: We identified hospital admissions with a primary diagnosis of ischemic stroke from the 2010 to 2012 MarketScan Commercial Claims and Encounters inpatient data sets, excluding those with capitated health insurance plans, aged <18 or >64 years, missing geographic region, hospital costs below the 1st or above 99th percentile, and having carotid intervention (n=40 082). We searched the data for AFib and analyzed the costs for nonrepeat and repeat stroke admissions separately. We estimated the AFib-associated costs using multivariate regression models controlling for age, sex, geographic region, and Charlson comorbidity index. RESULTS: Of the 33 500 nonrepeat stroke admissions, 2407 (7.2%) had AFib. Admissions with AFib cost $4991 more than those without AFib ($23 770 versus $18 779). For the 6582 repeat stroke admissions, 397 (6.0%) had AFib. The costs were $3260 more for those with AFib than those without ($24 119 versus $20 929). After controlling for potential confounders, AFib-associated costs for nonrepeat stroke admissions were $4905, representing 20.6% of the total costs for the admissions. Both the hospital costs and the AFib-associated costs were associated with age, but not with sex. AFib-associated costs for repeat stroke admissions were not significantly higher than for non-AFib patients, except for those aged 55 to 64 years ($3537). CONCLUSIONS: AFib increased the hospital cost of ischemic stroke substantially. Further investigation on AFib-associated costs for repeat stroke admissions is needed.
Authors: James V Freeman; Ruo P Zhu; Douglas K Owens; Alan M Garber; David W Hutton; Alan S Go; Paul J Wang; Mintu P Turakhia Journal: Ann Intern Med Date: 2010-11-01 Impact factor: 25.391
Authors: Anna Ringborg; Robby Nieuwlaat; Peter Lindgren; Bengt Jönsson; Dogan Fidan; Aldo P Maggioni; Jose Lopez-Sendon; Janina Stepinska; Dennis V Cokkinos; Harry J G M Crijns Journal: Europace Date: 2008-03-07 Impact factor: 5.214
Authors: Sonja V Sorensen; Sarah Dewilde; Daniel E Singer; Samuel Z Goldhaber; Brigitta U Monz; Jonathan M Plumb Journal: Am Heart J Date: 2009-06 Impact factor: 4.749
Authors: Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner Journal: Circulation Date: 2017-01-25 Impact factor: 29.690
Authors: Gursukhman D S Sidhu; Tarek Ayoub; Abdel Hadi El Hajjar; Aneesh Dhorepatil; Saihariharan Nedunchezian; Lilas Dagher; Keith Ferdinand; Nassir Marrouche Journal: CJC Open Date: 2022-02-10
Authors: C D Streib; S Rangaraju; D T Campbell; D G Winger; S L Paolini; A J Zhang; B T Jankowitz; A P Jadhav; T G Jovin Journal: AJNR Am J Neuroradiol Date: 2018-12-27 Impact factor: 3.825
Authors: J'Neka S Claxton; Pamela L Lutsey; Richard F MacLehose; Lin Y Chen; Tené T Lewis; Alvaro Alonso Journal: J Stroke Cerebrovasc Dis Date: 2018-12-21 Impact factor: 2.136
Authors: San-Shuai Chang; Jia-Hui Wu; Yi Liu; Ting Zhang; Xin Du; Jian-Zeng Dong; Gregory Y H Lip; Chang-Sheng Ma Journal: Chronic Dis Transl Med Date: 2018-02-26
Authors: Saeha Shin; Richard T Burnett; Jeffrey C Kwong; Perry Hystad; Aaron van Donkelaar; Jeffrey R Brook; Mark S Goldberg; Karen Tu; Ray Copes; Randall V Martin; Ying Liu; Alexander Kopp; Hong Chen Journal: Environ Health Perspect Date: 2019-08-26 Impact factor: 9.031
Authors: Siti Norain Azahar; Saperi Sulong; Wan Asyraf Wan Zaidi; Norliza Muhammad; Yusof Kamisah; Norliana Masbah Journal: Int J Environ Res Public Health Date: 2022-01-19 Impact factor: 3.390